搜尋結果
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 1 日前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
Here's a point-by-point rundown on why we're buying more of 3 portfolio stocks
CNBC· 12 小時前... Jim Cramer's Charitable Trust will own: 840 shares of SWK, increasing its weighting ...
Amgen investors await weight-loss drug data
Reuters· 2 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Boeing's Cash Goal Is $10 Billion in Dead Weight
Bloomberg· 7 日前CEO’s decision to stick with an ambitious target sends the wrong message.
The Best Walking Shoes For Flat Feet, According To A Podiatrist
Forbes· 1 日前The best walking shoes for flat feet evenly redistribute your body weight to alleviate stress on your ...
Novo Trades at Hefty Discount to Lilly Even After 350% Rally
Bloomberg· 16 小時前... A/S’s more than 350% rally over the past four years may have further to run if the weight ...
Losing Weight Is No Joke When You Have Long Covid
Bloomberg· 3 日前... where I recently bought a bathroom scale to help me figure out how to lose the weight& ... ...
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum? - What’s News - WSJ Podcasts
The Wall Street Journal· 19 小時前Emily Field: This morning, Novo talked about a quadrupling of new patients starting Wegovy on a weekly basis in the United ...
What Social Media May Not Tell You About Weight-Loss Drugs - Tech News Briefing - WSJ Podcasts ...
The Wall Street Journal· 7 日前Coming up on today's show, a hack into healthcare technology company Change Healthcare has ...
Karen Firestone: Tech dominates the S&P 500. It's time to ask whether it's the best ...
CNBC· 3 日前For many decades, the key professional goal of many in the investment management industry has ...